Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
Patrick Gellings, Ashley A. Wilkins, Lisa A. Morici
Pathogens (2020) Vol. 9, Iss. 12, pp. 1066-1066
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Vaccinomics to Design a Multi-Epitopes Vaccine for Acinetobacter baumannii
M. Kamal Uddin, Aqel Albutti, Asad Ullah, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 9, pp. 5568-5568
Open Access | Times Cited: 42
Subunit vaccines for Acinetobacter baumannii
Ning Yang, Xiao Jin, Chenghua Zhu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 25
Drug‑resistant Acinetobacter baumannii: From molecular mechanisms to potential therapeutics (Review)
Hao-Jia Wu, Zhi-Gang Xiao, Xiaojuan Lv, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 5
Open Access | Times Cited: 25
Development of a novel multi-epitope subunit mRNA vaccine candidate to combat Acinetobacter baumannii
Shiyang Ma, Fei Zhu, Peipei Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Vaccine development for bacterial pathogens: Advances, challenges and prospects
Ifeanyi Elibe, Hyelnaya Cletus Sharndama, Zikora Kizito Glory Anyaegbunam, et al.
Tropical Medicine & International Health (2023) Vol. 28, Iss. 4, pp. 275-299
Open Access | Times Cited: 21
The Prevalence of Multidrug-Resistant Acinetobacter baumannii and Its Vaccination Status among Healthcare Providers
Ayman Elbehiry, Eman Marzouk, Ihab Mohamed Moussa, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1171-1171
Open Access | Times Cited: 20
Synthetic Pseudaminic-Acid-Based Antibacterial Vaccine Confers Effective Protection against Acinetobacter baumannii Infection
Ruohan Wei, Xuemei Yang, Han Liu, et al.
ACS Central Science (2021) Vol. 7, Iss. 9, pp. 1535-1542
Open Access | Times Cited: 34
Hypothetical adhesin CAM87009.1 formulated in alum or biogenic silver nanoparticles protects mice from lethal infection by multidrug-resistant Acinetobacter baumannii
Stella Buchhorn de Freitas, Amilton Clair Pinto Seixas Neto, Luciano Aparecido Panagio, et al.
Vaccine (2024) Vol. 42, Iss. 18, pp. 3802-3810
Closed Access | Times Cited: 5
BauA and Omp34 surface loops trigger protective antibodies against Acinetobacter baumannii in a murine sepsis model
Zahra Akbari, Iraj Rasooli, Mohammad Hossein Ghaini, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108731-108731
Closed Access | Times Cited: 20
Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: Are vaccines and adjuvants effective strategies?
Yue Hu, Xianqin Zhang, Shanshan Deng, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Development of a multi-epitope vaccine against Acinetobacter baumannii: A comprehensive approach to combating antimicrobial resistance
Masoumeh Beig, Mohammad Sholeh, Safoura Moradkasani, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319191-e0319191
Open Access
Advances in actinobacteria-based bioremediation: mechanistic insights, genetic regulation, and emerging technologies
Naureenbanu Makarani, R. S. Kaushal
Biodegradation (2025) Vol. 36, Iss. 2
Closed Access
Healthcare-Associated Infections: The Role of Microbial and Environmental Factors in Infection Control—A Narrative Review
A Sandu, Mariana Carmen Chifiriuc, Corneliu Ovidiu Vrâncianu, et al.
Infectious Diseases and Therapy (2025)
Open Access
Exploring the Antimicrobial Potential of Moringa Oleifera Extracts Against Acinetobacter Baumannii
Saima Pervaiz, Afshan Zia, Nida Javed, et al.
Pakistan Journal of Health Sciences (2025), pp. 252-258
Closed Access
Engineering a multi-epitope chimera derived from Acinetobacter baumannii CAM87009.1 and FilF fimbriae proteins: immunogenic and antibiofilm activity
Pâmela Scaraffuni Caballero, Isabel Ladeira Pereira, Stella Buchhorn de Freitas, et al.
Brazilian Journal of Microbiology (2025)
Closed Access
Analysis of Antimicrobial and Antibiofilm Activity of Human Milk Lactoferrin Compared to Bovine Lactoferrin against Multidrug Resistant and Susceptible Acinetobacter baumannii Clinical Isolates
Tyra M. Avery, RaNashia L. Boone, Jacky Lu, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 8, pp. 2116-2126
Open Access | Times Cited: 26
Outer Membrane Vesicles from Acinetobacter baumannii: Biogenesis, Functions, and Vaccine Application
Zheqi Weng, Ning Yang, Shujun Shi, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 49-49
Open Access | Times Cited: 8
Total Synthesis of an All-1,2-cis-Linked Repeating Unit from the Acinetobacter baumannii D78 Capsular Polysaccharide
Dancan K. Njeri, Justin R. Ragains
Organic Letters (2022) Vol. 24, Iss. 19, pp. 3461-3465
Open Access | Times Cited: 14
Comparison of phenotypic and genotypic assays of biofilm formation in A. baumannii isolates based on gold standard method and related antibiotic resistance
Mohamed M. Sehree, Hanaa N. Abdullah, Amani M. Jasim
Gene Reports (2022) Vol. 27, pp. 101575-101575
Closed Access | Times Cited: 13
Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis
Elisabet Bjånes, Jiarong Zhou, Tariq Qayum, et al.
Advanced NanoBiomed Research (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 11
Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii
Houda Haddad, Radhia Mejri, Alyne Rodrigues de Araújo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 171-171
Open Access | Times Cited: 2
Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System
Michal Magda, Serena Bettoni, Maisem Laabei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa
Mohammad Reza Rahbar, Shaden M.H. Mubarak, Anahita Hessami, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Investigation of Peptidoglycan-Associated Lipoprotein of Acinetobacter baumannii and Its Interaction with Fibronectin To Find Its Therapeutic Potential
Vandana Solanki, Monalisa Tiwari, Vishvanath Tiwari
Infection and Immunity (2023) Vol. 91, Iss. 5
Open Access | Times Cited: 6
Global Risk Maps of Climate Change Impacts on the Distribution of Acinetobacter baumannii Using GIS
Amal Sabour
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2174-2174
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top